Journal List > Korean J Lab Med > v.29(5) > 1011578

Park, Ko, Kim, and Song: Performance Evaluation of the Piccolo xpress Point-of-care Chemistry Analyzer

Abstract

Background:

Point-of-care (POC) tests are used increasingly due to fast results and simple test procedures, which enables rapid diagnosis and therapeutic monitoring. We evaluated the performance of the Piccolo xpress Chemistry Analyzer (Abaxis, USA) a POC chemistry analyzer.

Methods:

Fourteen analytes, Na+, K+, Cl-, Ca2+, total carbon dioxide, AST, ALT, total bilirubin, alkaline phosphatase, blood urea nitrogen, creatinine, albumin, total protein, and glucose; were measured simultaneously with a 100 μL of whole blood sample using a Comprehensive Metabolic Reagent disk. Within-run and total precision and linearity were evaluated according to CLSI EP15-A and EP6-A guidelines, respectively. Comparison with a central laboratory chemistry analyzer was performed using 144 patient samples.

Results:

The coefficients of variations of within-run and total precision were all within 5% for three levels except for total carbon dioxide, ALT, alkaline phosphatase, total bilirubin, and creatinine in low level, and creatinine in middle level. The results of 14 analytes were linear within a commonly encountered range in clinical samples (r2≥0.98). More than 10% of samples in Na+, AST, ALT, glucose, BUN did not satisfy CLIA analytical quality requirement.

Conclusions:

The Piccolo xpress Chemistry Analyzer can analyze multiple analytes with a minimal amount of whole blood in a short time. It showed an acceptable performance for precision, linearity and comparison with central laboratory analyzer. It can be useful as a screening tests modality in mobile clinics, ambulances, and field clinics for military use, and for pediatric patients from whom enough sample volume is difficult to obtain.

REFERENCES

1.Nichols JM. Point of care testing. Clin Lab Med. 2007. 27:893–908.
crossref
2.Min WK. The trend of clinical chemistry. Medical Postgraduates. 2003. 31:251–4. (민원기. 임상화학의현황. 녹십자의보 2003;31:251-4.).
3.Clinical and Laboratory Standards Institute. User verification of performance for precision and trueness; Approved guideline-2nd edi. Document EP15-A2. Wayne, PA: Clinical and Laboratory Standards Institute;2005. p. 25.
4.Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; Approved guideline. Document EP6-A. Wayne, PA: Clinical and Laboratory Standards Institute;2003. p. 23.
5.Clinical and Laboratory Standards Institute. Method comparison and bias estimation using patient samples; Approved guideline-2nd edi. Document EP9-A2. Wayne, PA: Clinical and Laboratory Standards Institute;2002. p. 22.
6.Mestric ZF., Perkov S. Comparability of point-of-care whole-blood electrolyte and substrate testing using a Stat Profile Critical Care Xpress analyzer and standard laboratory methods. Clin Chem Lab Med. 2006. 44:898–903.
crossref
7.Drenck NE. Point of care testing in critical care medicine: the clinician's view. Clin Chim Acta. 2001. 307:3–7.
crossref
8.Tortella BJ., Lavery RF., Lavery RF., Siegel JH. Precision, accuracy, and managed care implications of a hand-held whole blood analyzer in the prehospital setting. Clin Chem. 1996. 106:124–7.
crossref
9.Ricos C., Alverez V., Caba F., Garcia-Lario JV., Hernandez A., Jiminez CV, et al. Current databases on biologic variation: pros, cons, and progress. Scand J Clin Lab Invest. 1999. 59:491–500.
10.Barrett AE., Cameron SJ., Fraser CG., Penberthy LA., Shand KL. A clinical view of analytical goals in clinical biochemistry. J Clin Pathol. 1979. 32:893–6.
crossref
11.Harding PJ., Fraser CG. Biological variation of blood acidbase status: consequences for analytical goal-setting and interpretation of results. Clin Chem. 1987. 33:1416–8.
crossref
12.Kost GJ., VU HT., Inn M., DuPlantier R., Fleisher M., Kroll MH, et al. Multicenter study of whole-blood creatinine, total carbon dioxide content, and chemistry profiling for laboratory and point-of care testing in critical care in the United States. Crit Care Med. 2000. 28:2379–89.
13.Zady FM. Z-STATS 12: correlation and simple least squares regression. [Westgard Website]. Available at. www.westgard.com/lesson42.htm. Accessed December 6,. 2006.
14.Westgard J. Charts of operational process specifications (“OPSpecs charts”) for assessing the precision, accuracy, and quality control needed to satisfy proficiency testing performance criteria. Clin Chem. 1992. 38:1226–33.
crossref
15.Yi SG., Lee SY., Kim JW. Evaluation of the i-STAT point-of-care testing analyzer. Korean J Lab Med. 2002. 22:304–11. ((이상곤, 이수연, 김종원. 현장검사기기 i-STAT 의평가. 대한진단검사의학회지 2002;22:304-11.).
16.Vanavanan S., Chittamma A. Performance of a multi-profile critical care testing analyzer. Clin Chem Lab Med. 2008. 46:9–14.
crossref
17.Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed.Missouri: Elsevier Saunders;2006. :47.

Fig. 1.
Measuring sequence of Piccolo xpress Chemistry Analyzer. (A) Blood sample is applied and diluent container is opened. (B) Diluent and blood sample enter the quality control cuvettes and blood sample enters the centrifugal chamber. (C) Centrifuge is performed. (D) Centrifuged sample and diluent are mixed. (E) The assay cuvettes are filled and analysis is performed (This schematic diagram was permitted from Abaxis system).
kjlm-29-430f1.tif
Fig. 2.
Correlations of 14 analytes of Comprehensive Metabolic Reagent disk between Piccolo xpress Chemistry Analyzer and TBA 200-FR. Dashed line indicates mean bias.
Abbreviations: tCO2, total carbon dioxide; ALP, alkaline phosphatase; BUN, blood urea nitrogen.
kjlm-29-430f2.tif
Table 1.
Principles of procedures of Piccolo xpress Chemistry Analyzer
Analyte Principle
Albumin Dye-Binding BCP
ALP PNPP, AMP buffer
ALT UV without P5P
AST UV without P5P
BUN Urease with GLDH (coupled enzyme)
Ca2+ Arsenazo III Dye
Cl- Enzymatic Reaction (activation of α-amylase)
Creatinine Enzymatic Reaction (creatinine amidohydrolase/Sarcosine oxidase)
Glucose Hexokinase, Colorimetry
K+ Enzymatic Reaction (activation of pyruvate kinase)
Na+ Enzymatic Reaction (activation of β-galactosidase)
tCO2 Enzymatic Reaction (PEPC)
Total bilirubin Enzymatic bilirubin oxidase
Total Protein Biuret

Abbreviations: ALP, alkaline phosphatase; BUN, blood urea nitrogen; tCO2, total carbon dioxide.

Table 2.
Precision of the Piccolo xpress Chemistry Analyzer by Liquid Unassayed Multiqual®
Analytes (unit) Cases N Mean Within-run Total
SD CV (%) SD CV (%)
Na+ (mmol/L) Low 20 110.6 1.44 1.3 1.33 1.2
  Middle 20 138.7 1.53 1.1 2.22 1.6
  High 20 157.9 1.74 1.1 2.05 1.3
K+ (mmol/L) Low 20 2.1 0.08 3.9 0.07 3.5
  Middle 20 3.8 0.09 2.4 0.10 2.5
  High 20 7.1 0.16 2.3 0.16 2.2
Cl- (mmol/L) Low 20 85.5 0.95 1.11 1.07 1.25
  Middle 20 98 1.27 1.3 1.76 1.8
  High 20 114.3 1.71 1.5 1.71 1.5
Ca2+ (mg/dL) Low 20 5.8 0.27 4.6 0.26 4.5
  Middle 20 9.4 0.25 2.7 0.23 2.4
  High 20 11.7 0.46 3.9 0.43 3.7
tCO2 (mmol/L) Low 20 17.5 1.00 5.7 0.98 5.6
  Middle 20 23.8 0.98 4.1 1.09 4.6
  High 20 29.2 1.34 4.6 1.31 4.5
AST (U/L) Low 20 41 0.94 2.3 1.15 2.8
  Middle 20 100.4 1.31 1.3 1.20 1.2
  High 20 218.9 1.75 0.8 2.63 1.2
ALT (U/L) Low 20 28.9 3.09 10.7 3.50 12.1
  Middle 20 77.9 2.10 2.7 2.65 3.4
  High 20 163.4 3.27 2 3.43 2.1
ALP (U/L) Low 20 34 3.47 10.2 3.09 9.1
  Middle 20 181.7 4.36 2.4 4.18 2.3
  High 20 390.7 5.86 1.5 5.08 1.3
Total bilirubin (mg/dL) Low 20 0.6 0.05 7.8 0.05 8
  Middle 20 2.8 0.04 1.3 0.07 2.5
  High 20 6.3 0.08 1.2 0.11 1.7
Albumin (g/dL) Low 20 2.8 0.09 3.2 0.10 3.5
  Middle 20 3.7 0.11 2.9 0.11 2.9
  High 20 4.5 0.07 1.5 0.10 2.2
Total protein (g/dL) Low 20 4.2 0.09 2.1 0.08 2
  Middle 20 5.6 0.05 0.9 0.05 0.9
  High 20 7.1 0.09 1.2 0.09 1.3
BUN (mg/dL) Low 20 14.5 0.52 3.6 0.52 3.6
  Middle 20 35.9 0.93 2.6 0.90 2.5
  High 20 66.5 0.67 1 1.06 1.6
Creatinine (mg/dL) Low 20 0.7 0.11 15.1 0.09 13.3
  Middle 20 1.9 0.11 5.9 0.11 5.6
  High 20 6.4 0.12 1.8 0.10 1.6
Glucose (mg/dL) Low 20 66.7 1.53 2.3 1.87 2.8
  Middle 20 126.1 0.88 0.7 1.13 0.9
  High 20 359.2 2.51 0.7 2.87 0.8

Abbreviations: tCO2, total carbon dioxide; ALP, alkaline phosphatase; BUN, blood urea nitrogen.

Table 3.
Linearity of the Piccolo xpress Chemistry Analyzer
Analytes Unit Range Slope Intercept R2 Analytes Unit Range Slope Intercept R2
Na+ mmol/L 132.2-162.3 1.000 <0.001 0.9900 ALP U/L 29.5-827.5 1.000 <0.001 0.9997
K+ mmol/L 4.3-8.3 1.000 <0.001 0.9821 Total bilirubin mg/dL 0.6-5.1 1.000 <0.001 0.9995
Cl- mmol/L 101.3-123.0 1.000 <0.001 0.9759 Glucose g/dL 74.0-495.8 1.000 <0.001 0.9999
Ca2+ mg/dL 9.3-14.8 1.000 <0.001 0.9955 BUN g/dL 8.3-51.5 1.000 <0.001 0.9987
tCO2 mmol/L 19.3-30.5 1.000 <0.001 0.9829 Creatinine mg/dL 0.6-8.9 1.000 <0.001 0.9988
AST U/L 25.8-1,093.3 1.000 <0.001 0.9998 Albumin mg/dL 3.7-5.7 1.000 <0.001 0.9933
ALT U/L 21.0-1,931.8 1.000 <0.001 0.9999 Total protein mg/dL 7.1-9.0 1.000 <0.001 0.9905

Abbreviations: tCO2, total carbon dioxide; ALP, alkaline phosphatase; BUN, blood urea nitrogen.

Table 4.
Correlations between Piccolo xpress Chemistry Analyzer and TBA 200-FR
Analytes Unit Range Slope (95% CI) Intercept (95% CI) Bias (Mean±SD) P value Bias% (Mean±SD) CLIA requirement Percent of samples not satisfying CLIA requirement R
Na+ mmol/L 110-170 0.977 (0.919-1.036) 6.0 (-2.1-14.2) 2.9±4.0 <0.001 2.1±3.2 Target±4 34.7 0.9355
K+ mmol/L 2.9-8.5 0.968 (0.942-0.993) 0.19 (0.05-0.33) 0.0±0.2 0.198 0.8±5.1 Target±0.5 1.4 0.9874
Cl- mmol/L 80-133 0.943 (0.907-0.978) 4.8 (1.0-8.7) -1.4±2.8 <0.001 -1.3±2.6 Target±5% 4.2 0.9748
Ca2+ mg/dL 6.4-16.0 0.955 (0.930-0.980) 0.75 (0.49-1.01) 0.3±0.5 <0.001 3.4±5.5 Target±1.0 3.5 0.9879
tCO2 mmol/L 10-37 0.696 (0.592-0.799) 9.4 (7.0-11.9) 2.3±3.5 <0.001 11.9±16.5 NA NA 0.6534
AST U/L 16-269 0.889 (0.877-0.902) 11.8 (11.2-12.4) 8.0±5.1 <0.001 41.9±28.2 Target±20% 10.5 0.9966
ALT U/L 8-560 0.846 (0.834-0.858) 11.2 (10.4-12.1) 5.5±10.9 <0.001 47.6±56.1 Target±20% 42.7 0.9965
ALP U/L 30-601 0.798 (0.786-0.810) 5.4 (3.4-7.4) -19.4±25.4 <0.001 -13.4±7.0 Target±30% 0 0.9960
Total bilirubin mg/dL 0.4-13.4 0.902 (0.891-0.913) 0.17 (0.15-0.20) 0.1±0.23 0.006 19.5±26.8 Target±0.4 or ±20% (greater) 1.4 0.9973
Glucose g/dL 44-451 0.938 (0.916-0.960) -0.5 (-3.5-2.5) -7.9±9.4 <0.001 -1.9±58.2 Target±6 or ±10% (greater) 25.0 0.9905
BUN g/dL 5-101 0.982 (0.968-0.997) -0.9 (-1.3~-0.6) -1.3±1.4 <0.001 -6.3±11.8 Target±2 or ±9% (greater) 14.7 0.9963
Creatinine mg/dL 0.2-10.8 1.045 (1.033-1.057) -0.26 (-0.28~-0.23) -0.2±0.2 <0.001 -21.1±15.9 Target±0.3 or ±15% (greater) 2.2 0.9978
Albumin mg/dL 1.6-4.9 1.058 (1.011-1.105) -0.61 (-0.80~-0.42) -0.4±0.2 <0.001 -10.1±6.9 Target±10% 3.5 0.9646
Total protein mg/dL 4.3-9.5 1.080 (1.024-1.136) -0.34 (-0.72-0.04) 0.2±0.3 <0.001 3.0±4.0 Target±10% 2.8 0.9520

P values were determined by using the paired t-test.

Percentage of the samples which does not satisfy CLIA requirement derived from the regression equation.

Abbreviations: tCO2, total carbon dioxide; ALP, alkaline phosphatase; BUN, blood urea nitrogen.

TOOLS
Similar articles